| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 01/22/2003 | EP1277751A1 2- and 2,5-substituted phenylketo-enols |
| 01/22/2003 | EP1277749A1 2- and 2,5-substituted phenylketo enols |
| 01/22/2003 | EP1277738A1 Condensed heteroaryl derivatives |
| 01/22/2003 | EP1277735A1 2- and 2,5-substituted phenylketo-enols |
| 01/22/2003 | EP1277734A1 2- and 2,5-substituted phenylketo-enols |
| 01/22/2003 | EP1277733A1 2- and 2,5-substituted phenylketo-enols |
| 01/22/2003 | EP1276741A1 Phenyl substituted 4-hydroxy tetrahydropyridone |
| 01/22/2003 | EP1276740A2 Novel epothilone derivatives, method for the preparation thereof and their pharmaceutical use |
| 01/22/2003 | EP0968213B1 Alkynyl-substituted camptothecins and process for their preparation |
| 01/22/2003 | EP0646115B1 Heterocyclic-cyclic amine derivatives |
| 01/22/2003 | CN1099420C Substituted spiroheterocyclic 1H-3-arylpyrrolidine-2-4,-dione derivatives, methods of preparing them and their use as pest-control agents |
| 01/21/2003 | US6509346 Chemokine receptor antagonists and methods of use therefor |
| 01/21/2003 | US6509345 For therapy of cancerous diseases |
| 01/21/2003 | US6509344 Indenoisoquinolines as antineoplastic agents |
| 01/21/2003 | US6509341 The invention relates to carboxylic acid derivatives of formula (I), wherein the substituents have the meaning as commented in the description. It also relates to the production and use of same as endothelin receptor antagonists. |
| 01/21/2003 | US6509340 Amide and urea derivatives as 5-HT reuptake inhibitors and as 5-HT1B/1D ligands |
| 01/16/2003 | WO2003004501A2 (hetero) aryl substituted benzofurans as 5-ht ligands |
| 01/16/2003 | WO2003004495A1 Novel immunomodulating compounds |
| 01/16/2003 | WO2003004488A1 Indazole benzimidazole compounds as tyrosine and serine/threonine kinase inhibitors |
| 01/16/2003 | WO2003004467A2 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use |
| 01/16/2003 | WO2003004032A1 Oral administration of 6-hydroxy-oxymorphone for use as an analgesic |
| 01/16/2003 | WO2003004031A1 Parenteral administration of 6-hydroxy-oxymorphone for use as an analgesic |
| 01/16/2003 | WO2003004030A1 Oxymorphone controlled release formulations |
| 01/16/2003 | WO2003004020A1 Heteroaryl carboxylic acid amides, the production thereof and the use of the same as inhibitors of the microsomal triglyceride transfer protein (mtp) |
| 01/16/2003 | WO2002050062A3 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors |
| 01/16/2003 | WO2002046129A3 Inhibitors of histone deacetylase |
| 01/16/2003 | US20030013757 Aromatic dicarboxylic acid derivatives |
| 01/16/2003 | US20030013715 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 01/16/2003 | US20030013603 Catalyst for oxidation, carbonylation, nitration, sulfonation |
| 01/16/2003 | US20030013041 Write-once optical data carrier |
| 01/16/2003 | US20030012831 Liquid-liquid extraction being carried out in the first stage at a pH-value of about 4; treating narrow-angle glaucoma, Alzheimer's disease, as well as alcohol and nicotine dependence. |
| 01/16/2003 | CA2452874A1 Oral administration of 6-hydroxy-oxymorphone for use as an analgesic |
| 01/16/2003 | CA2452872A1 Parenteral administration of 6-hydroxy-oxymorphone for use as an analgesic |
| 01/16/2003 | CA2452609A1 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use |
| 01/16/2003 | CA2451749A1 Novel immunomodulating compounds |
| 01/16/2003 | CA2451606A1 (hetero) aryl substituted benzofurans as 5-ht ligands |
| 01/15/2003 | EP1274713A1 Anti-viral pyrimidine nucleoside analogues |
| 01/15/2003 | EP1274431A1 10,11-difluoromethylenedioxycamptothecin compounds with topoisomerase i inhibition |
| 01/15/2003 | CN1391473A VLA-4 inhibitor compounds |
| 01/15/2003 | CN1390834A Indenoindolone compounds, their preparation and medicinal compositions containing them |
| 01/14/2003 | US6506876 LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use |
| 01/14/2003 | US6506773 Hydroxamic and carboxylic acid derivatives |
| 01/14/2003 | US6506769 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 01/14/2003 | US6506766 Glucocortiocoid-selective antinflammatory agents |
| 01/14/2003 | US6506507 Methine compound, material for organic luminescence element, and organic luminescence element using the same |
| 01/14/2003 | CA2217477C Tricyclic compounds useful for inhibition of farnesyl protein transferase |
| 01/09/2003 | WO2003002715A2 Compositions and methods for labeling oligonucleotides |
| 01/09/2003 | WO2003002561A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 01/09/2003 | WO2003002548A1 A process for the preparation of chiral glucocorticoid receptor agents |
| 01/09/2003 | WO2002080152A3 Optical data carrier that contains a heterocyclic azo dye as the light-absorbing compound in the information layer |
| 01/09/2003 | WO2002059111A3 Pyrazole compounds useful as protein kinase inhibitors |
| 01/09/2003 | US20030009031 Useful for the inhibition of polymerization |
| 01/09/2003 | US20030008910 Use of proteasome inhibitors to treat dry eye disorders |
| 01/09/2003 | US20030008898 Indole derivatives and their use for the treatment of malignant and other diseases based on pathological proliferation |
| 01/09/2003 | US20030008848 Small molecules useful in the treatment of inflammatory disease |
| 01/09/2003 | US20030008234 Optical data carrier comprising a cyanine dye as light-absorbent compound in the information layer |
| 01/09/2003 | US20030007941 Method of treating hair loss using thyromimetic compounds |
| 01/09/2003 | US20030006516 Radiation transparent subsrates; reflecting layer |
| 01/09/2003 | CA2451464A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 01/08/2003 | EP1273584A1 2- or 4-Chromenyliden based merocyanines and use thereof |
| 01/08/2003 | EP1272491A1 Perylene-derivative based crystallization modifiers |
| 01/08/2003 | EP1272484A2 Benzoamide piperidine compounds as substance p antagonists |
| 01/08/2003 | EP1272480A1 Method for the production of spirocyclic tetronic acid derivatives |
| 01/08/2003 | EP1272192A2 A use of galantamine for the treatment of neuropsychiatric behaviour associated with alzheimer's disease |
| 01/08/2003 | EP1272168A2 Small organic molecule regulators of cell proliferation |
| 01/08/2003 | EP1095011A4 Novel fluorescent lanthanide chelates |
| 01/08/2003 | EP1053239B1 Glucocorticoid-selective anti-inflammatory agents |
| 01/08/2003 | EP0863878B1 Cyclic nitrones and pharmaceutical compositions containing them |
| 01/08/2003 | CN1390221A Spiro (2H-1-benzopyran-2,4'-piperididine) derivates as glycine transport inhibitors |
| 01/08/2003 | CN1389203A Method for treating hair-dropping using thyromimetic compound |
| 01/08/2003 | CN1098266C Fused pyrrolo (2,3-c) carbazole-6-one which potentiate activity of gamma interferon |
| 01/07/2003 | US6504036 2- and 2.5-substituted phenylketoenols |
| 01/07/2003 | US6504029 Condensed-hexacyclic compounds and a process therefor |
| 01/07/2003 | US6503926 Nitrogen heterocycle compounds |
| 01/07/2003 | US6503919 Compounds of 7-oxo-2,3,7,14-tetrahydro-1H-benzo[b]pyrano[3,2-h]acridin carboxylate |
| 01/07/2003 | US6503899 Azepino[4,5-b]pyrano[3,2-e]indoles |
| 01/03/2003 | WO2003000697A1 Furoisoquinoline derivative, process for producing the same, and use |
| 01/03/2003 | WO2003000691A1 Carboline derivatives as pdev inhibitors |
| 01/03/2003 | WO2003000677A1 Spiropiperidine compounds as ligands for orl-1 receptor |
| 01/03/2003 | WO2003000676A1 1,2,4-trioxolane antimalarials |
| 01/03/2003 | WO2003000265A1 Crystalline anticholinergic, method for its production, and use thereof in the production of a drug |
| 01/03/2003 | WO2003000240A2 Stable powder inhalation dosage formulation |
| 01/03/2003 | WO2002046170A8 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 01/03/2003 | WO2001083800A8 Heterologous production of polyketides |
| 01/03/2003 | CA2450550A1 Spiropiperidine compounds as ligands for orl-1 receptor |
| 01/02/2003 | US20030004355 Regulating intracellular levels of cyclic guanosine-3*,5*-monophosphate by activiating soluble guanylate cyclase or inhibiting phosphodiesterases |
| 01/02/2003 | US20030004351 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 01/02/2003 | US20030004344 Thrombin or factor Xa inhibitors |
| 01/02/2003 | US20030004338 Antitumor, anticancer agents |
| 01/02/2003 | US20030004208 Squalene synthetase inhibitors; antilipemic agents, anticholesterol agents |
| 01/02/2003 | US20030004183 Quinoline-4-carboxamide derivatives as NK-2 and NK-3 receptor antagonists |
| 01/02/2003 | US20030004172 Cardiovascular disorders, osteoporosis, multiple sclerosis, antiarthritic agents |
| 01/02/2003 | US20030004166 Novel triazine compounds useful as sorbitol dehydrogenase inhibitors |
| 01/02/2003 | US20030004164 Anticancer agents; autoimmune diseases |
| 01/02/2003 | US20030004162 Antidiabetic agents; dietetics |
| 01/02/2003 | US20030004161 Anticancer agents; autoimmune diseases |
| 01/02/2003 | US20030004150 New analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them |
| 01/02/2003 | US20030003396 Reflection, protective or covering layers which can be written on or read by blue, red or infrared light |
| 01/02/2003 | EP1270579A1 Process for producing camptothecin |
| 01/02/2003 | EP1270578A1 Novel process for producing fused imidazopyridine derivative and novel crystal form |